7th Jul 2025 16:21
7 July 2025
VENTURE LIFE GROUP PLC
("Venture Life", "VLG" or the "Company")
Director/PDMR Shareholding
Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that Paul McGreevy, Non-Executive Chairman, has today purchased an aggregate of 66,776 ordinary shares of 0.3 pence each in the capital of the Company ("Ordnary Shares") at a volume-weighted average price of 59.90 pence per Ordinary Share.
Following the purchases, Mr McGreevy beneficially holds 963,825 Ordinary Shares representing approximately 0.75 per cent. of the Company's issued share capital.
For further information, please contact:
Venture Life Group PLC | +44 (0) 1344 578004 | ||
Jerry Randall, Chief Executive Officer Daniel Wells, Chief Financial Officer | |||
Cavendish Capital Markets Limited (Nomad and Broker) |
+44 (0) 20 7720 0500 | ||
Stephen Keys / George Lawson (Corporate Finance) Michael Johnson (Sales) |
| ||
| |||
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on commercialising products for the global self-care market. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health and Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.
The Company makes the following disclosure in accordance with article 19(3) of the Market Abuse Regulation:
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||||
a)
| Name
| Paul McGreevy | ||||||||
2
| Reason for the notification
| |||||||||
a)
| Position/status
| Non-Executive Chairman | ||||||||
b)
| Initial notification /Amendment
| Initial notification | ||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||||
a)
| Name
| Venture Life Group plc | ||||||||
b)
| LEI
| 213800S8CZUPLAB2KC70 | ||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 0.3p each in Venture Life Group plc
GB00BFPM8908 | ||||||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||||||
c)
| Price(s) and volume(s)
|
| ||||||||
d)
| Aggregated information
- Aggregated volume
- Price
| 66,776 Ordinary Shares purchased at a volume-weighted average price of 59.90 pence
| ||||||||
e)
| Date of the transaction
| 7 July 2025 | ||||||||
f)
| Place of the transaction
| London Stock Exchange
| ||||||||
Related Shares:
Venture Life